WCN25-1211 ACUTE KIDNEY INJURY FROM MONONUCLEAR CELL-PREDOMINATED INTERSTITIAL NEPHRITIS AFTER THE INTRODUCTION OF GLUCAGON-LIKE PEPTIDE-1 AGONISTS: A CASE REPORT

WCN25-1211 ACUTE KIDNEY INJURY FROM MONONUCLEAR CELL-PREDOMINATED INTERSTITIAL NEPHRITIS AFTER THE INTRODUCTION OF GLUCAGON-LIKE PEPTIDE-1 AGONISTS: A CASE REPORT

Saved in:

Bibliographic Details
Main Authors:	Raweekarn Itsathitpaisarn, Thana Thongsricome, Nattavong Suksawad, Watsapol Wongwikrom
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924021429
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-1040 Drug-Induced Acute Interstitial Nephritis
by: Nermine Ben Achour, et al.
Published: (2024-04-01)

WCN24-1038 Histological Characteristics of Acute Interstitial Nephritis
by: Nermine Ben Achour, et al.
Published: (2024-04-01)

WCN24-1211 To determine the effectiveness of Lactoferrin in improving Anemia in iron replete CKD patients
by: Kushal Kekan, et al.
Published: (2024-04-01)

Nephroprotective potential of glucagon-like peptide-1 receptor agonists
by: Minara S. Shamkhalova, et al.
Published: (2020-04-01)

Glucagon‐like peptide‐1 receptor agonists and kidney outcomes
by: Richard J. MacIsaac, et al.
Published: (2024-10-01)

Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology
by: Е. L. Nasonov, et al.
Published: (2024-04-01)

Therapeutic strategies, consequences and prospects of glucagon-like peptide-1 agonists
by: N.M. Bobok
Published: (2025-05-01)

WCN25-393 URINARY BIOMARKERS FOR NON INVASIVE DIAGNOSIS OF ACUTE INTERSTITIAL NEPHRITIS
by: Tamilselvan Palanisamy, et al.
Published: (2025-02-01)

Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges
by: Zhi Dong Zhou, et al.
Published: (2025-06-01)

Sildenafil Induced Acute Interstitial Nephritis
by: Ryan Burkhart, et al.
Published: (2015-01-01)

WCN25-1139 ANTIPLATLET AND STATIN THERAPY FOR THE PRIMARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HEMODIALYSIS PATIENTS: A CASE-CONTROL STUDY
by: Passawee Chevasath, et al.
Published: (2025-02-01)

Efficacy of Dual Glucagon and Glucagon-like Peptide-1 Receptor Agonists Across the Cardiometabolic Continuum: A Review of Current Clinical Evidence
by: Panagiotis Stachteas, et al.
Published: (2025-07-01)

As várias faces das monjas cistercienses em Portugal (1211-1385)
by: Luís Miguel Rêpas
Published: (2023-01-01)

Multiomics insight into the role of glucagon‐like peptide‐1 receptor agonists in heart failure
by: Yuhang Tao, et al.
Published: (2025-08-01)

Patient-reported outcomes of glucagon-like peptide-1 agonists on hidradenitis suppurativa severity
by: Radhika Gupta, BA, et al.
Published: (2025-08-01)

Mechanism of glucagon-like peptide-1 receptor agonist in the treatment of obesity and food addiction
by: LIU Luyao, LI Linwei, WANG Chen, DI Jianzhong
Published: (2025-06-01)

The Effect of Glucagon-Like Peptide-2 Receptor Agonists on Colonic Anastomotic Wound Healing
by: Heather A. Redstone, et al.
Published: (2010-01-01)

Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists
by: Rui Song, et al.
Published: (2022-01-01)

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
by: Gagik R. Galstyan, et al.
Published: (2017-10-01)

The current and changing role of glucagon-like peptide-1 receptor agonists in knee osteoarthritis
by: Anne D. Holleman, et al.
Published: (2025-09-01)

The therapeutic effects and mechanisms of glucagon-like peptide-1 receptor agonists in neurocognitive disorders
by: Junchen Si, et al.
Published: (2025-04-01)

Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Mechanisms, Efficacy, and Safety
by: Michał Stasiak, et al.
Published: (2025-06-01)

Research progress on mechanisms of glucagon-like peptide-1 receptor agonists in diabetic retinopathy
by: HE Cuihuan, SHI Derong, SUN Dandan, LI Yurui, XIA Guanghao
Published: (2025-02-01)

Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review
by: Aleksander Jentkiewicz, et al.
Published: (2025-02-01)

Glucagon‐Like Peptide‐1 Receptor Agonists and Anesthesia—Are We Clearer on the Correct Approach?
by: Zachary Bloomgarden
Published: (2024-12-01)

Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients
by: Luis Alberto Vigara, et al.
Published: (2024-11-01)

WCN25-1839 APPLYING SPOT URINE SODIUM TO POTASSIUM RATIO IN A STANDARDIZED SPOT URINE COLLECTION TO IMPROVE THE ACCURACY OF 24-HOUR URINE SODIUM EXCRETION ESTIMATION
by: Thana Thongsricome, et al.
Published: (2025-02-01)

Reversible Fluindione-Induced Chronic Interstitial Nephritis
by: Thomas Crepin, et al.
Published: (2016-01-01)

Granulomatous Interstitial Nephritis Presenting as Hypercalcemia and Nephrolithiasis
by: Saika Sharmeen, et al.
Published: (2016-01-01)

Drug-Induced Acute Interstitial Nephritis with Nifedipine
by: Léonard Golbin, et al.
Published: (2016-01-01)

Predictors of Kidney Recovery in Acute Interstitial Nephritis
by: Naoko Nakaosa, et al.
Published: (2025-01-01)

WCN25-1196 RADIONUCLIDE IMAGING OF THE PARATHYROID GLANDS TO PREDICT MEDICATION RESPONSE FOR HYPERPARATHYROIDISM IN CHRONIC KIDNEY DISEASE AND DIALYSIS
by: Panchanit Yongkiatkan, et al.
Published: (2025-02-01)

Association of Glucagon‐Like Peptide Agonist Therapy With Dietary Patterns in a Cross‐Sectional Cohort
by: Eric J. Brandt, et al.
Published: (2025-06-01)

Health Disparity Clusters of Off Label Prescriptions for Glucagon-Like Peptide 1 Receptor Agonists
by: Kateri J. Spinelli, et al.
Published: (2025-06-01)

Efficacy and Safety of Glucagon‐Like Peptide‐1 Agonists for Psychiatric Symptoms: A Systematic Review
by: Shakila Meshkat, et al.
Published: (2025-07-01)

Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective
by: Yosra Turkistani
Published: (2025-04-01)

Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery
by: R. R. C. New, et al.
Published: (2024-11-01)

Effects of Glucagon like Peptide-1 agonists on patients with overactive bladder: A pilot study
by: Max D. Sandler, et al.
Published: (2025-06-01)

Meta-analysis of the efficacy of glucagon-like peptide-1 receptor agonists in the treatment of diabetic nephropathy
by: Ze-jin Liao, et al.
Published: (2024-12-01)

Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
by: Nina A. Petunina, et al.
Published: (2018-09-01)